
Amnon Schlegel MD PhD, EMBA (He/Him)
Diabetes, Lipid Metabolism, Obesity, Osteoporosis & Bone Metabolism Medicine
Clinical development Director, Amgen Adjunct Associate Professor, Biochemistry, and Nutrition and Integrative Physiology, University of Utah
Join to view full profile
One Amgen Center DrSuite 100Thousand Oaks, CA 91320
Phone+1 800-282-6436
Fax+1 650-275-4254
Dr. Schlegel is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Amnon Schlegel is an adult endocrinologist affiliated with Ultragenyx Pharmaceuticals.
Education & Training
Quantic School of Business and TechnologyEMBA, Business, With Honors, 2024 - 2025
University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 2004 - 2007
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2002 - 2004
Albert Einstein College of MedicineClass of 2002
Hofstra UniversityBS, Biochemistry (major), Mathematics (minor), Summa Cum Laude with High Honors in Biochemistry, 1992 - 1996
Certifications & Licensure
UT State Medical License 2010 - 2028
CA State Medical License 2004 - 2027
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 2 citationsSuccessful diagnosis and monitoring of giant prolactinomas: the role of sample dilutions.Amnon Schlegel, Joely A Straseski
Laboratory Medicine. 2025-11-22 - 22 citationsTERN-501 monotherapy and combination therapy with TERN-101 in metabolic dysfunction-associated steatohepatitis: the randomized phase 2a DUET trial.Mazen Noureddin, Naim Alkhouri, Eric J Lawitz, Kris V Kowdley, Rohit Loomba
Nature Medicine. 2025-07-01 - 1 citationsDiagnostic challenge of an APOB variant of uncertain significance resolved by transheterozygosity with a pathological LDLR variant and clinical response to therapy.Amnon Schlegel
Atherosclerosis. 2024-03-01
Press Mentions
A Look at How a Doctor on the Front Lines of the Coronavirus Takes Precautions to Avoid Exposing Her FamilyApril 14th, 2020- Glucocorticoids with or Without Fludrocortisone in Septic ShockAugust 30th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: